Report: Medtronic helped draft, edit medical journal articles
A US Senate Finance Committee report alleges that Medtronic was heavily involved in drafting, editing and shaping the content of medical journal articles authored by its physician consultants involving its InFuse bone growth product used in spine surgery. This information was not disclosed, raising serious questions about the research conducted. Medtronic was paid $210 million over several years through royalties and consulting fees.
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Why Open Payments Irks Physicians
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- IV Fluids Shortage Continues
- Difficult Patients: It's Not Them, It's You, Doctor
- Overcoming a Payer Mix 'Nightmare'
- Employee Engagement: Make It Meaningful
- Proton Beam Therapy Center Closure Illuminates Costs